Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors.

Autor: Leung CH; Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China. duncanl@hkbu.edu.hk, Chan DS, Kwan MH, Cheng Z, Wong CY, Zhu GY, Fong WF, Ma DL
Jazyk: angličtina
Zdroj: ChemMedChem [ChemMedChem] 2011 May 02; Vol. 6 (5), pp. 765-8. Date of Electronic Publication: 2011 Mar 01.
DOI: 10.1002/cmdc.201100016
Databáze: MEDLINE